Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease
2022/45/N/NZ7/01418
Keywords
Descriptors
- NZ3_005: Neurobiologia molekularna
- NZ7_012: Prewencja chorób człowieka
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Instytut Farmakologii PAN
Voivodeship: małopolskie
Principal investigator (from the host institution)
Karolina Barbara Przepiórska-Drońska
Number of co-investigators in the project: 3
Call
PRELUDIUM 21 – announced on 2022-03-28
- Amount awarded
- 210 000 PLN
- Project start date
- 2023-02-02
- Project end date
- 2027-02-01
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.